Their opinion isn't even necessary. It would be enlightening to know what percentage of the trial sites COVID ICU patients are currently receiving Leronlimab. I would think Open label usage and EIND requests raw numbers would be public information. We were able to obtain the raw numbers in the past. Those numbers at the trial sites would speak for themselves. I imagine if it works they'd be passing it out like Candycorn on Halloween. If no open label requests at any trial site, you have your answer.